This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: The General Hospital Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Johnathan R. Whetstine: Cancer Research and Patent Innovation
Introduction
Johnathan R. Whetstine is an inventor associated with Winchester, Massachusetts. His patent work concerns cancer research, including approaches to regulating EGFR amplification in cancer cells to improve the efficacy of targeted treatments.
Latest Patents
Whetstine is listed as an inventor on 1 patent: “Compositions and Methods for Regulating EGFR Amplification in Cancer Cells for Improving Efficacy of EGFR-Targeted Anti-Cancer Agents.” The invention focuses on methods and compositions intended to address EGFR amplification and support the effectiveness of EGFR-targeted anticancer agents.
Career Highlights
The provided information associates Whetstine with The General Hospital Corporation and the Institute for Cancer Research. These organizations are connected with his work in cancer research and the development of approaches relevant to targeted therapies.
Collaborations
Whetstine’s listed coworkers include Thomas L. Clarke and Elnaz Atabakhsh. Their names appear alongside his in connection with collaborative research and patent activity.
Conclusion
Johnathan R. Whetstine’s patent activity reflects a focus on cancer research, particularly strategies for regulating EGFR amplification to improve targeted anticancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile